Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen

被引:54
|
作者
Apt, D
Raviprakash, K
Brinkman, A
Semyonov, A
Yang, SM
Skinner, C
Diehl, L
Lyons, R
Porter, K
Punnonen, J
机构
[1] Maxygen Inc, Human Therapeut, Redwood City, CA 94063 USA
[2] USN, Med Res Ctr, Viral Dis Dept, Silver Spring, MD 20910 USA
[3] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
关键词
dengue virus; antigen; tetravalent; multivalent antigen; DNA shuffling; cross-neutralizing antibodies;
D O I
10.1016/j.vaccine.2005.07.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We employed DNA shuffling and screening technologies to develop a single recombinant dengue envelope (E) antigen capable of inducing neutralizing antibodies against all four antigenically distinct dengue serotypes. By DNA shuffling of codon-optimized dengue 1-4 E genes, we created a panel of novel chimeric clones expressing C-terminal truncated E antigens that combined epitopes from all four dengue serotypes. DNA vaccines encoding these novel chimeras induced multivalent T cell and neutralizing antibody responses against all four dengue serotypes in mice. By contrast, a mixture of four unshuffled, parental DNA vaccines failed to produce tetravalent neutralizing antibodies in mice. length neutralizing antibody titers for some of these antigens could be further improved by extending the sequences to express full membrane and envelope proteins. The chimeric antigens also protected mice against a lethal dengue-2 virus challenge. These data demonstrate that DNA shuffling and associated screening can lead to the selection of multi-epitope antigens against closely related dengue virus serotypes and suggest a broad utility for these technologies in optimizing vaccine antigens. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [41] EVALUATION OF THE EFFECT OF PRE-EXISTING IMMUNITY AGAINST DENGUE ON NEUTRALIZING ANTIBODY RESPONSE INDUCED BY A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE CANDIDATE, KD-382, IN CYNOMOLGUS MONKEYS
    Takagi, Shota
    Yoshimura, Masaya
    Kameyama, Kazuhisa
    Shinmura, Yasuhiko
    Sonoda, Kengo
    Kino, Yoichiro
    Yoksan, Sutee
    Fujii, Takashi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 246 - 246
  • [42] A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
    Raviprakash, Kanakatte
    Luke, Thomas
    Doukas, John
    Danko, Janine
    Porter, Kevin
    Burgess, Timothy
    Kochel, Tadeusz
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1764 - 1768
  • [43] QUALITY OF THE ANTIBODY RESPONSE INDUCED BY A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE IN NAIVE AND DENGUE EXPOSED INDIVIDUALS
    White, Laura
    Stoops, Mark
    Swanstrom, Jesica
    Young, Ellen
    Mukherjee, Swati
    Dean, Hansi
    Baric, Ralph
    de Silva, Aravinda
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 506 - 507
  • [44] Co-circulation of all four dengue virus serotypes with concurrent infections in a single dengue season
    Mishra, B.
    Turuk, J.
    Sahu, S. J.
    Khajuria, A.
    Kumar, S.
    Dey, A.
    Praharaj, A. K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 446 - 446
  • [45] Antiviral Activity of Rosmarinic Acid Against Four Serotypes of Dengue Virus
    Panchal, Ritesh
    Ghosh, Saikat
    Mehla, Rajeev
    Ramalingam, Jayachandran
    Gairola, Sunil
    Mukherjee, Sandeepan
    Chowdhary, Abhay
    CURRENT MICROBIOLOGY, 2022, 79 (07)
  • [46] Antiviral Activity of Rosmarinic Acid Against Four Serotypes of Dengue Virus
    Ritesh Panchal
    Saikat Ghosh
    Rajeev Mehla
    Jayachandran Ramalingam
    Sunil Gairola
    Sandeepan Mukherjee
    Abhay Chowdhary
    Current Microbiology, 2022, 79
  • [47] Dengue and dengue hemorrhagic fever among adults: Clinical outcomes related to viremia, serotypes, and antibody response
    Guilarde, Adriana O.
    Turchi, Marilia D.
    Siqueira, Joao Bosco, Jr.
    Feres, Valeria C. R.
    Rocha, Benigno
    Levi, Jose E.
    Souza, Vanda A. U. F.
    Boas, Lucy Santos Vilas
    Pannuti, Claudio S.
    Martelli, Celina M. T.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (06): : 817 - 824
  • [48] Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
    Osorio, Jorge E.
    Huang, Claire Y. -H.
    Kinney, Richard M.
    Stinchcomb, Dan T.
    VACCINE, 2011, 29 (42) : 7251 - 7260
  • [49] Simultaneous quantitation of neutralizing antibodies against all four dengue virus serotypes using optimized reporter virus particles
    Lingemann, Matthias
    Amaro-Carambot, Emerito
    Lamirande, Elaine W.
    Pierson, Theodore C.
    Whitehead, Stephen S.
    JOURNAL OF VIROLOGY, 2024, 98 (07)
  • [50] Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
    Injampa, Subenya
    Muenngern, Nataya
    Pipattanaboon, Chonlatip
    Benjathummarak, Surachet
    Boonha, Khwanchit
    Hananantachai, Hathairad
    Wongwit, Waranya
    Ramasoota, Pongrama
    Pitaksajjakul, Pannamthip
    PEERJ, 2017, 5